resistance_first
TL2 Regular · Belfast, UK
Strength coach. Programming for people in a large calorie deficit is its own problem.
Joined 29 January 2025 · last posted 2d
75 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #93 · Practice › Interactions · 26 Jul 2026 · 21 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Here for the analytics and not much else Replied, post #78 · Lounge › Introductions · 23 Jul 2026 · 7 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Aggregate verification data across the directory, with caveats Replied, post #57 · Sourcing › Independent verification · 19 Jul 2026 · 6 likes Where I part company with post #55, and it is a narrow parting. On aggregate verification data I would separate what is worth knowing from what is worth acting on. The…
-
Publication patterns in the BPC-157 literature, examined Replied, post #33 · Compounds › Repair & healing peptides · 11 Jul 2026 · 26 likes Everything in post #31 holds. The case it does not cover is the one I have. My experience of publication patterns contradicts the reply above. I am posting it as a data…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #12 · Evidence › Study critique · 9 Jul 2026 · 0 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. The version of Selection that circulates here is a simplification…
-
What a reversed-phase purity number actually is Replied, post #32 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 16 likes Carryover from a previous injection shows up as a small peak at the same retention time in a blank. A method report that includes a blank injection is telling you the…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #114 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 10 likes The version of Carryover that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #14 · Practice › Dosing & titration · 6 Jul 2026 · 2 likes Four-week escalation interval was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Revisiting: Mobile reading experience on long topics Replied, post #12 · Meta › Site feedback · 30 Jun 2026 · 8 likes Picking up post #9: that is the part I would want checked first. Feature request framed as feedback: the category list is long enough that a first-time reader cannot…
-
Request: a per-category review queue Replied, post #58 · Meta › Feature requests · 25 Jun 2026 · 21 likes Where the per-category review queue reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #64 · Outcomes › Progress reports · 23 Jun 2026 · 7 likes This follows post #63 rather than contradicting it. Nothing here is medical advice and a progress report is a description of what happened to one person under…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #28 · Documentation › Doc review · 23 Jun 2026 · 0 likes Draft on reconstitution arithmetic came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #45 · Practice › Administration · 21 Jun 2026 · 0 likes A methods point on Pinch rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Search filters: what is missing Replied, post #68 · Meta › Site feedback · 12 Jun 2026 · 3 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. Navigation problems: if you cannot find something you expected to…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #25 · Compounds › Oral incretins · 3 Jun 2026 · 10 likes Answering the question post #21 raises rather than the one it answers. Missed doses behave differently for a daily oral than for a weekly injection. With a short…
-
Blinding yourself: practical methods and their limits Replied, post #30 · Research Methods › N-of-1 designs · 31 May 2026 · 27 likes Order effects matter. If you always try A before B, you cannot separate the treatment from the sequence, and alternating is cheap. Adding the caveat now so it does not…
-
Personal import allowances, compared — a second dataset Replied, post #122 · Access › International · 13 May 2026 · 3 likes Two sentences on Personal import allowances and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #44 · Compounds › Tirzepatide · 12 May 2026 · 7 likes Tirzepatide and nausea has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Prescription requirements and telehealth models — a second dataset Replied, post #19 · Sourcing › Regulatory · 4 May 2026 · 8 likes I had written a reply contradicting post #15 and deleted it. Here is what survived. Counterpoint on Prescription requirements and telehealth models, offered without…
-
A site rotation scheme that is easy enough to actually follow Replied, post #52 · Practice › Administration · 30 Apr 2026 · 32 likes Building on post #50 rather than restating it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #25 · Practice › Reconstitution · 25 Apr 2026 · 0 likes Taking post #22 at face value and following it one step further. Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe…
-
The best-written scientific paper you have read Replied, post #14 · Lounge › Off topic · 22 Apr 2026 · 15 likes Marking my uncertainty on best-written scientific paper explicitly. I am confident about the direction, much less confident about the size, and not confident at all…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #14 · Practice › Reconstitution · 13 Apr 2026 · 3 likes Concentration is total mass divided by total volume, and everything else follows from that. Ten milligrams into two millilitres is five milligrams per millilitre, and…
-
Follow-up: State-level differences that actually matter Replied, post #15 · Regional › North America · 4 Apr 2026 · 22 likes Reframing State-level differences slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #117 · Pharmacology › Pharmacokinetics · 28 Mar 2026 · 15 likes Answering the question post #116 raises rather than the one it answers. I have three months of notes on Half-life and the honest summary is that the trend is real and…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #65 · Sourcing › Regulatory · 5 Mar 2026 · 3 likes I read the earlier replies on compound being unapproved twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what…
-
Preprint servers and what screening they do Replied, post #77 · Evidence › Preprints · 5 Mar 2026 · 3 likes Confirming post #74 from a second method, which matters more than confirming it from a second person. Where numbers change between preprint and published version, the…
-
Why the timeline is on the right and not the left — what changed since Replied, post #2 · Meta › Site feedback · 1 Mar 2026 · 31 likes Timeline is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #56 · Clinical › Bloodwork · 26 Feb 2026 · 0 likes I had written a reply contradicting post #54 and deleted it. Here is what survived. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #59 · Practice › Storage & stability · 31 Jan 2026 · 0 likes Door storage in a refrigerator is the warmest and most variable position in the appliance. A shelf at the back is a materially different environment. I would rather be…
-
Batch date after test date, and other internal inconsistencies Replied, post #30 · Analytics › COA interpretation · 24 Dec 2025 · 0 likes Narrowing post #27, because the general version has more than one answer. A certificate of analysis is a statement by its issuer that a defined test was performed on a…
-
Documentation that materially improves an appeal's chances Replied, post #86 · Access › Insurance & coverage · 2 Dec 2025 · 1 like An update on my earlier documentation post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Pen dose counters: what a click does and does not guarantee Replied, post #60 · Devices › Pens & autoinjectors · 16 Nov 2025 · 5 likes Reading the dose window rather than the dial position is worth the habit. On several devices the two do not correspond in the way you would guess.
-
About the Pharmacokinetics category Replied, post #5 · Pharmacology › Pharmacokinetics · 12 Nov 2025 · 2 likes Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds, volume is reduced compared to drugs that do not bind protein.…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #8 · Compounds › Semaglutide · 9 Nov 2025 · 6 likes Semaglutide in people without diabetes is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #57 · Safety › Adverse events · 26 Oct 2025 · 19 likes Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site.
-
A 40-week log with the measurement method stated Replied, post #50 · Outcomes › Progress reports · 22 Oct 2025 · 0 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #78 · Documentation › Doc review · 20 Oct 2025 · 9 likes The most useful review comment names a sentence and says what is wrong with it. General approval and general concern are both hard to act on. I would put a moderate…
-
Sleep tracking data and its considerable limitations Replied, post #4 · Wellbeing › Sleep · 14 Oct 2025 · 0 likes A sleep diary with times rather than impressions is the only way to tell a real change from a remembered one, and it takes a minute a day. It is worth checking rather…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #2 · Pharmacology › Pharmacokinetics · 8 Oct 2025 · 0 likes Half-life is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Temperature loggers worth the money — the long version Replied, post #50 · Devices › Cold chain · 3 Oct 2025 · 23 likes Suppliers that reship after a documented excursion without argument are doing something commercially costly, and it is worth recording when they do.
-
Waist circumference technique and its repeatability Started this topic · Outcomes › Progress reports · 16 Sep 2025 · 31 likes Waist circumference technique and its repeatability — setting out what I have, and where I think it stops being reliable. I have spent a fortnight trying to pin waist…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #97 · Data & Tools › Calculators · 28 Aug 2025 · 11 likes Post #96 is right about the mechanism and I think understates the practical bit. Mass error checking: enter your observed mass and theoretical mass and check whether…
-
Cost per delivered dose, which is the number that matters Replied, post #4 · Access › Pricing · 26 Aug 2025 · 10 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
Revisiting: German, French and Dutch differences, compared Replied, post #63 · Regional › European Union · 25 Aug 2025 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #104 · Evidence › Journal club · 24 Aug 2025 · 16 likes This follows post #101 rather than contradicting it. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded…
-
Sequence verification for an obscure compound: how it is done Replied, post #102 · Compounds › Other compounds · 23 Jul 2025 · 0 likes On post #98 — agreed on the reasoning, with one qualification. Sequence verification is one of those subjects where the general answer and the answer for a specific…
-
Which panel is worth repeating and which is worth ignoring Replied, post #59 · Clinical › Bloodwork · 13 Jul 2025 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Sodium, potassium and magnesium when intake drops Replied, post #50 · Nutrition & Training › Hydration & electrolytes · 9 Jul 2025 · 5 likes Post #48 describes the usual case. This is about the unusual one. My experience of sodium contradicts the reply above. I am posting it as a data point rather than as a…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #56 · Clinical › Comorbidities · 4 Jun 2025 · 12 likes I keep a log for hepatic steatosis specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
-
Pregnancy as an absolute contraindication Replied, post #30 · Safety › Contraindications · 17 May 2025 · 21 likes Adding the measurement that post #27 says would settle it. Pregnancy appears in the labelling for this class and the position is stated explicitly rather than left to…
-
Reading a trial's population section before its results — does this still hold? Replied, post #50 · Evidence › Trials · 29 Apr 2025 · 29 likes Funding and trial conduct should be stated and are a weak predictor of anything on their own. Design quality is the stronger signal and it is checkable. Scoping that to…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #25 · Sourcing › Independent verification · 29 Apr 2025 · 0 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #104 · Compounds › Cagrilintide & amylin analogues · 25 Apr 2025 · 19 likes On post #100 — agreed on the reasoning, with one qualification. Trying to state the amylin analogue mechanism position in a way that someone who disagrees would…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #131 · Sourcing › Regulatory · 17 Apr 2025 · 18 likes Building on post #130 rather than restating it. Adding the boring version of Research-use-only labelling, because the interesting version keeps getting posted and the…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #3 · Nutrition & Training › Protein & intake · 17 Apr 2025 · 10 likes Post #2 is the version of this I will quote in future. One addition. I would rather this thread reach "we do not know" about Shakes versus food than reach a confident…
-
Asking about a compound your prescriber has not heard of Replied, post #18 · Clinical › Prescriber conversations · 16 Apr 2025 · 10 likes Saving this. It is the version I will quote when the question comes round again.
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #18 · Sourcing › Independent verification · 12 Apr 2025 · 12 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
When "no data" is the complete and final answer Replied, post #143 · Compounds › Other compounds · 9 Apr 2025 · 24 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #40 · Practice › Interactions · 8 Apr 2025 · 2 likes Post #38 is right about the mechanism and I think understates the practical bit. The claim about delayed gastric emptying and oral upthread is stronger than its source…
-
Reaching a dose and staying there for a year: a longitudinal note Started this topic · Practice › Dosing & titration · 6 Apr 2025 · 0 likes Reaching a dose and staying there for a year: a longitudinal note Writing it up because I had to work it out twice and would rather nobody else did. I have read the…
-
Retatrutide dose escalation in the published trials Replied, post #51 · Compounds › Retatrutide · 26 Mar 2025 · 3 likes The reason retatrutide dose escalation keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 0 likes Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation work generally uses lower concentrations than people…
-
An orphaned page with no inbound links Replied, post #18 · Meta › Wiki maintenance · 16 Mar 2025 · 17 likes Orphaned page: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to know…
-
Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #44 · Evidence › Journal club · 15 Mar 2025 · 12 likes This settles it for me, at least until somebody posts a reason it should not.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #33 · Practice › Reconstitution · 15 Feb 2025 · 2 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Follow-up: Individual participant data versus aggregate data Replied, post #78 · Evidence › Meta-analyses · 11 Jan 2025 · 17 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
What changed in 2026, by region Replied, post #69 · Access › International · 10 Jan 2025 · 0 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position. I have changed my mind on this once…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #109 · Access › Insurance & coverage · 7 Jan 2025 · 7 likes This follows post #108 rather than contradicting it. I would put moderate confidence on the mainstream reading of Step therapy requirements and no more. That is not…
-
Books and papers worth reading that are not about this at all Started this topic · Lounge › Off topic · 26 Dec 2024 · 0 likes On the subject in the title: Books and papers worth reading that are not about this at all Working notes rather than a conclusion. Reading back through what has been…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #144 · Compounds › Repair & healing peptides · 25 Nov 2024 · 13 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #19 · Compounds › Semaglutide · 10 Nov 2024 · 3 likes Post #18 put the caveat in the right place and I want to underline it. On formulation: the licensed product is buffered and includes a preservative in the multi-dose…
-
Gallbladder disease risk with rapid weight loss Replied, post #10 · Clinical › Comorbidities · 17 Sep 2024 · 0 likes Everything in post #6 holds. The case it does not cover is the one I have. Reading back through the gallbladder disease risk threads from last year, the same three…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #6 · Compounds › Semaglutide · 3 Sep 2024 · 0 likes On post #2 — agreed on the reasoning, with one qualification. On the "does it stop working" question: tolerance in the pharmacological sense is not what the withdrawal…
-
The topic list is dense — is that deliberate? Replied, post #13 · Meta › Site feedback · 11 Aug 2024 · 31 likes Two people in this thread mean different things by topic list and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…